Feeding village children in Mindanao Philippines and watching my boy and girl grow up.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Enlighten me. What material information has he disclosed?
That is an explicitly well written and emotionally charged depiction of your experience and emotions with a happy ending that you are fortunate to have but too many are deprived. God bless you and your wife.
It could be a trilogy like "The Godfather". It could show the first company trying to get something approved in 1906 with bags of cash (before brief cases) being given under the table.
But Estrada appears to have gotten it very quickly.
CFO said on the call yesterday when talking about dividends that the only dividend to be paid is on the Preferred and according to Delaeare law dividends are not payable until there is positive equity in the company. Go listen.
Yes, it is the part where he talks about his disappointment in the FDA re Leronlimab.
Dr. Been hits the nail on the head re the FDA.
Thumbs up.
Thanks for the breakdown. I agree.
Alot of support in the 2.00 area. We need a red to green day.
It has been my experience that unless you are dealing with an Enron type situation where there is fraud involved, that stocks seldom go straight down or straight up. The further you stretch the rubber band the harder the snapback.
Fundamentally, any good news from PI, Canada or any other front will result in a move to 3.20-4.06
That does not mean that we couldnot eventually come back down after the rally. The chart needs work.
Best of luck to you.
Good to see you posting. Smart move. I have been in and out. I sold yesterday at 3+ and bought back today at 2.25 just for the oversold bounce that should come.
For a bottim look for capitulation volume and going from red to green. With RSI at 25 it could be soon.
As I said, support is 2.25 and resistance is 4.05. For traders I would be a buyer at 2.25 and a seller at 4.05. For long term holders it does not matter.
My hope was that the 200 day sma would hold at 4.05. That did not happen and now it needs work. The RSI is at 30 which is oversold short term. I posted charts on Twitter this morning (Friar Tuck). Support in the 2.25 area, resistance 4.00 (200 day sma). GLTA
Got this from Twitter, which was a link from Reddit.
Dr. Woodcock,
CytoDyn released its top-line results for severe/critical COVID-19 this weekend, and it was nothing short of phenomenal. As you’re likely well-aware, the trial achieved statistical significance by decreasing hospitalization by 6 days in intubated patients. When adjusted for age, leronlimab was the first drug ever to achieve a statistically significant mortality benefit (p=.03) in a randomized, placebo controlled trial.
You have the power, and I would argue the ethical obligation, to grant an EUA based on this data. That decision is yours - and yours alone. Almost 540,000 Americans have died in this pandemic. How many of them could leronlimab have saved? How many of the more than 40,000 hospitalized today could benefit from leronlimab? The data unequivocally suggests leronlimab could save a lot of lives.
Moreover, the decision to grant an EUA based on age-adjusted and subgroup data isn’t unfounded. In the RECOVERY trial, the data for Decadron was age-adjusted and parsed into subgroups (intubated, oxygen, no oxygen) for its landmark data which is now the standard of care. Also, note that the RECOVERY trial was open-label.
CytoDyn’s trial of leronlimab was double-blinded, placebo (SoC) controlled and showed statistically significant benefits in mortality for critically ill patients and mortality benefit across the entire trial population in combination with Decadron (when age-adjusted), and length of stay in intubated patients was statistically significant even without the adjustment. Through no fault of its own, the age imbalance between trial arms (DSMC should have caught this) is literally now a life or death unfortunate event.
You have openly said that you don’t think people should die for a p-value. However, that’s exactly what you’re allowing right now by not issuing an EUA for leronlimab. I implore you to re-evaluate that decision and appeal to your humanity. Would you want your family member to get leronlimab if intubated or the current standard of care? I would want leronlimab.
As an emergency physician, I’ve admitted hundreds of patients - many of them to die - without any hope that they would live. Leronlimab gives those patients hope. It gives families hope. It gives me hope. But, for that hope to become reality, it is desperately needed for an EUA to be issued.
I beg you to issue the EUA. I don’t want any more of my patients to die without the hope leronlimab will provide to them and their families.
Respectfully,
John Bream, MD, FACEP
Dr. Woodcock's Twitter handle is @DrWoodcockFDA
I will tweet her also.
Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung
Transplantation Program, commented, “The CD12 trial results are very promising
and leronlimab may be the only safe medication to help critically ill
patients.”
Rock, do you mind if I share this on Twitter?
DANG, that is a bold statement. But I would not let possible corruption in areas you can not control dictate the waste of years of education and helpful healing to those in need of it.
Another interesting site
"reddit: the front page of the internet" https://www.reddit.com/r/CYDY/
Difference between IM long acting monthly drug Cabenuva and Leronlimab..
CABENUVA
--Cabotegravir
--Rilpivirine
Long acting drug , given with 2 IM, very painful injections , each treatment..
--must be given by health care professional,( IM injection.)
We see possibility of very serious problems,
--WARNINGS , not to use with Hepatitis B and C , may produce liver damage .
--besides common cold , diarrhea , headache , some serious side effect observed ..
--2 very painful injections , about 1% of patients discontinued because of severe pain.Also serious reaction during injection or soon after observed , dyspnea , agitation , flushing , sweating , changes of blood pressure.
--All together about 3 % of patients discontinued because of severity of some side effects.
--Depression and suicidal thoughts .
--significant weigh gain.
--Advise not to use during pregnancy or breast feeding.
--Not recommended for less then 12 years old.
--patients may develop resistance.
--Not to use in resistant patients
--possible kidney damage
--possible liver damage
--possibility of severe Hypersensitivity Reactions .
--Immune Reconstitution Syndrome was reported. , Autoimmune disorders like Graves disease , polymyositis , Guillan - Barre syndrome , and autoimmune hepatitis , also was reported..
--interaction with MANY drugs , one really need to be very healthy in order to use it .
--And VERY , VERY important , if side effects will appear , side effects are also long acting. Residual concentrations of cabotegravil and Rilpivirine may remain in system up to 12 months or longer.
Now-- LERONLIMAB..
--Self SC injection, once a week
--Can be use for HIV drug resistant patients.
--do not produce resistance.
--even patients resistant to Maraviroc responding to Leronlimab.
-- about 60% of HIV patients have some liver problems , look that leronlimab maybe helpful , NASH study ongoing.
--more patients with HIV have different malignancies , Leronlimab most probably will help, cancer studies ongoing.
--SO FAR NOT ONE SERIOUS SIDE EFFECT..not one patient needed to discontinue treatment.
So we only need to educate doctors and our patients..IMO..
So glad to hear she is doing well. Continued prayers.
Twas the night before Christmas and grinch and cohorts read the FDA guidance, needing to change their shorts.
They also heard Nader distinctively say, "Merry Christmas to shareholders, here's how I earn my pay".
Parabolic moves are falling knives to shorts.
June 12th pps was 3.02. June 30 it hit 10.01.
Breaking 6.75 puts next resistance 10.00.
Correction could be swift when it comes.
5.15 taken out bect resistance 6.75
http://stockcharts.com/h-sc/ui?s=CYDY&p=D&yr=0&mn=6&dy=10&id=p81287614714&a=857890025&listNum=1
This is the post I recall from you from 2 days ago when you said "don't read too much ito it".
No, not at all. Look at the run from December to February of last year. The RSI stayed over 70 the entire time.
http://stockcharts.com/h-sc/ui?s=CYDY&p=D&yr=1&mn=3&dy=10&id=p26127400519&a=857160457&listNum=1
Hope you have a peaceful holiday. I feel for you guys on the front lines. Respect.
There is an uptrend line that is best defined in the 30 minute chart.
http://stockcharts.com/h-sc/ui?s=CYDY&p=30&yr=0&mn=1&dy=10&id=p21662278825&a=857070498&listNum=1
Please annotate the downtrend line you are referring. This is the only one from $10 I can draw with three points.
http://stockcharts.com/h-sc/ui?s=CYDY&p=D&yr=0&mn=7&dy=10&id=p32557963022&a=856162009&listNum=1
They tried hard to close it below the 200 day sma but managed to close .01 above it. HGEN also closed above the 200 day sma today.